150 related articles for article (PubMed ID: 34753412)
21. Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure.
Cantor LB; Hoop J; Katz LJ; Flartey K;
Clin Ther; 2001 Jul; 23(7):1032-9. PubMed ID: 11519768
[TBL] [Abstract][Full Text] [Related]
22. Comparing the effects and safety of dorzolamide hydrochloride + timolol maleate versus brimonidine after neodymium-doped yttrium aluminium garnet laser capsulotomy posterior capsule opacification.
Çakmak K; Erbil H; Mesci C; Korkmaz Ş
Eur J Ophthalmol; 2022 Sep; 32(5):2928-2934. PubMed ID: 34791912
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of brimonidine in preventing intraocular pressure spikes following phacoemulsification in glaucoma patients.
Kandarakis A; Soumplis V; Karampelas M; Panos C; Kyriakos N; Baxevanakis A; Karagiannis D
Eur J Ophthalmol; 2010; 20(6):994-9. PubMed ID: 20544673
[TBL] [Abstract][Full Text] [Related]
24. Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy.
Singhal D; Desai R; Desai S; Shastri M; Saxena D
J Pharmacol Pharmacother; 2011 Apr; 2(2):104-6. PubMed ID: 21772770
[TBL] [Abstract][Full Text] [Related]
25. Comparison of wavefront aberrations in eyes with multifocal and monofocal iols before and after Nd:YAG laser capsulotomy for posterior capsule opacification.
Cinar E; Yuce B; Aslan F; Erbakan G
Int Ophthalmol; 2020 Sep; 40(9):2169-2178. PubMed ID: 32358733
[TBL] [Abstract][Full Text] [Related]
26. Intraocular pressure increase after Nd:YAG laser capsulotomy and anterior segment optical coherence tomography analysis.
Keles A; Karaman SK
Lasers Med Sci; 2023 Dec; 39(1):13. PubMed ID: 38135858
[TBL] [Abstract][Full Text] [Related]
27. Acute elevations of intraocular pressure following Nd:YAG laser posterior capsulotomy.
Slomovic AR; Parrish RK
Ophthalmology; 1985 Jul; 92(7):973-6. PubMed ID: 4022582
[TBL] [Abstract][Full Text] [Related]
28. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
29. The effects of Nd:YAG laser capsulotomy on anterior segment parameters in patients with posterior capsular opacification.
Oztas Z; Palamar M; Afrashi F; Yagci A
Clin Exp Optom; 2015 Mar; 98(2):168-71. PubMed ID: 25195519
[TBL] [Abstract][Full Text] [Related]
30. Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Rakofsky S; Koch DD; Faulkner JD; Terry SA; Mandell AI; Gross RL; Kelley EP; Iacono TL; Lue J
J Cataract Refract Surg; 1997 Sep; 23(7):1075-80. PubMed ID: 9379380
[TBL] [Abstract][Full Text] [Related]
31. Intraocular pressure control after Nd:YAG laser posterior capsulotomy in eyes with glaucoma.
Lin JC; Katz LJ; Spaeth GL; Klancnik JM
Br J Ophthalmol; 2008 Mar; 92(3):337-9. PubMed ID: 18211944
[TBL] [Abstract][Full Text] [Related]
32. The effects of Nd:YAG laser posterior capsulotomy on macular thickness, intraocular pressure, and visual acuity.
Ari S; Cingü AK; Sahin A; Çinar Y; Çaça I
Ophthalmic Surg Lasers Imaging; 2012; 43(5):395-400. PubMed ID: 22785102
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.
Ladas ID; Pavlopoulos GP; Kokolakis SN; Theodossiadis GP
Br J Ophthalmol; 1993 Mar; 77(3):136-8. PubMed ID: 8457502
[TBL] [Abstract][Full Text] [Related]
34. Intraocular pressure after neodymium:YAG laser treatments in the anterior segment.
Shani L; David R; Tessler Z; Rosen S; Schneck M; Yassur Y
J Cataract Refract Surg; 1994 Jul; 20(4):455-8. PubMed ID: 7932138
[TBL] [Abstract][Full Text] [Related]
35. Eradication of Posterior Capsule Opacification: Documentation of a Marked Decrease in Nd:YAG Laser Posterior Capsulotomy Rates Noted in an Analysis of 5416 Pseudophakic Human Eyes Obtained Postmortem.
Apple DJ; Peng Q; Visessook N; Werner L; Pandey SK; Escobar-Gomez M; Ram J; Auffarth GU
Ophthalmology; 2020 Apr; 127(4S):S29-S42. PubMed ID: 32200823
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the impact of Nd:YAG laser posterior capsulotomy on ocular pulse amplitude and anterior segment morphology.
Pekel G; Yağcı R; Acer S; Özdemir S; Sayin N
Lasers Surg Med; 2014 Sep; 46(7):553-7. PubMed ID: 24986133
[TBL] [Abstract][Full Text] [Related]
37. The complication rate following Neodymium-doped Yttrium Aluminum Garnet laser posterior capsulotomy for posterior capsular opacification in patients with and without comorbidities.
Joshi RS; Doble P
Indian J Ophthalmol; 2023 Mar; 71(3):791-796. PubMed ID: 36872680
[TBL] [Abstract][Full Text] [Related]
38. Analysis of influencing factors associated with the time between cataract surgery and Nd:YAG laser posterior capsulotomy.
Zhang Y; Wu Y; Liang J; Xie X; Wang H; Chi H; Yan H
Eur J Ophthalmol; 2023 Jul; 33(4):1616-1623. PubMed ID: 36740904
[TBL] [Abstract][Full Text] [Related]
39. The impact of Nd: YAG laser posterior capsulotomy by the use of "the circular pattern with vitreous strand cut" technique on anterior chamber parameters.
El-Haddad NSEM
Lasers Med Sci; 2019 Mar; 34(2):353-357. PubMed ID: 30105483
[TBL] [Abstract][Full Text] [Related]
40. Eradication of posterior capsule opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem.
Apple DJ; Peng Q; Visessook N; Werner L; Pandey SK; Escobar-Gomez M; Ram J; Auffarth GU
Ophthalmology; 2001 Mar; 108(3):505-18. PubMed ID: 11237905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
